100 related articles for article (PubMed ID: 15737208)
21. Changes in the peripheral blood T-Cell receptor V beta repertoire in vivo and in vitro during shigellosis.
Islam D; Wretlind B; Lindberg AA; Christensson B
Infect Immun; 1996 Apr; 64(4):1391-9. PubMed ID: 8606106
[TBL] [Abstract][Full Text] [Related]
22. T cell activation profiles in Kawasaki syndrome.
Brogan PA; Shah V; Clarke LA; Dillon MJ; Klein N
Clin Exp Immunol; 2008 Feb; 151(2):267-74. PubMed ID: 18070150
[TBL] [Abstract][Full Text] [Related]
23. Quantitative flow cytometric identification of aberrant T cell clusters in erythrodermic cutaneous T cell lymphoma. Implications for staging and prognosis.
Horna P; Deaver DM; Qin D; Moscinski LC; Sotomayor EM; Glass LF; Sokol L
J Clin Pathol; 2014 May; 67(5):431-6. PubMed ID: 24319102
[TBL] [Abstract][Full Text] [Related]
24. The use of anti-T-cell receptor-Vbeta antibodies for the estimation of treatment success and phenotypic characterization of clonal T-cell populations in cutaneous T-cell lymphomas.
Schwab C; Willers J; Niederer E; Ludwig E; Kündig T; Grob P; Burg G; Dummer R
Br J Haematol; 2002 Sep; 118(4):1019-26. PubMed ID: 12199780
[TBL] [Abstract][Full Text] [Related]
25. Utility of flow cytometry immunophenotyping and DNA ploidy studies for diagnosis and characterization of blood involvement in CD4+ Sézary's syndrome.
Lima M; Almeida J; dos Anjos Teixeira M; Queiros ML; Santos AH; Fonseca S; Balanzategui A; Justica B; Orfao A
Haematologica; 2003 Aug; 88(8):874-87. PubMed ID: 12935975
[TBL] [Abstract][Full Text] [Related]
26. CD4
Vonderheid EC; Hou JS
Leuk Lymphoma; 2018 Feb; 59(2):330-339. PubMed ID: 28595473
[TBL] [Abstract][Full Text] [Related]
27. CD4(+)CD7(-) T cells compose the dominant T-cell clone in the peripheral blood of patients with Sézary syndrome.
Rappl G; Muche JM; Abken H; Sterry W; Tilgen W; Ugurel S; Reinhold U
J Am Acad Dermatol; 2001 Mar; 44(3):456-61. PubMed ID: 11209115
[TBL] [Abstract][Full Text] [Related]
28. Genotypic, phenotypic and functional analysis of CD4+CD7+ and CD4+CD7- T lymphocyte subsets in Sézary syndrome.
Dummer R; Nestle FO; Niederer E; Ludwig E; Laine E; Grundmann H; Grob P; Burg G
Arch Dermatol Res; 1999 Jun; 291(6):307-11. PubMed ID: 10421055
[TBL] [Abstract][Full Text] [Related]
29. Germline transcription of multiple TCR-Vbeta genes in cloned T-cell lines.
Abbey JL; O'Neill HC
Immunol Cell Biol; 2004 Aug; 82(4):393-9. PubMed ID: 15283849
[TBL] [Abstract][Full Text] [Related]
30. Abnormal immunophenotype of the T-cell-receptor beta Chain in follicular-helper T cells of angioimmunoblastic T-cell lymphoma.
Mao ZJ; Surowiecka M; Linden MA; Singleton TP
Cytometry B Clin Cytom; 2015; 88(3):190-3. PubMed ID: 25619965
[TBL] [Abstract][Full Text] [Related]
31. Comparative study of cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma.
Nagatani T; Miyazawa M; Matsuzaki T; Iemoto G; Kim ST; Baba N; Miyamoto H; Nakajima H
Semin Dermatol; 1994 Sep; 13(3):216-22. PubMed ID: 7986691
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of genetically defined tumor cells in CD7 as well as CD26 positive and negative circulating T-cell subsets in Sézary syndrome.
Steinhoff M; Schöpp S; Assaf C; Muche M; Beyer M; Sterry W; Lukowsky A
Leuk Res; 2009 Jan; 33(1):88-99. PubMed ID: 18672285
[TBL] [Abstract][Full Text] [Related]
33. CD7-positive Sézary syndrome with a Th1 cytokine profile.
Yagi H; Tokura Y; Furukawa F; Takigawa M
J Am Acad Dermatol; 1996 Feb; 34(2 Pt 2):368-74. PubMed ID: 8655729
[TBL] [Abstract][Full Text] [Related]
34. Extracutaneous transformation into a high-grade lymphoma: a potential pitfall in the management of patients with Sézary syndrome.
Michaelis S; Kazakov DV; Burg G; Dummer R; Kempf W
Int J Dermatol; 2006 Mar; 45(3):277-9. PubMed ID: 16533228
[TBL] [Abstract][Full Text] [Related]
35. Heterogeneity of circulating CD4+ memory T-cell subsets in erythrodermic patients: CD27 analysis can help to distinguish cutaneous T-cell lymphomas from inflammatory erythroderma.
Fierro MT; Novelli M; Quaglino P; Comessatti A; Fava P; Ortoncelli M; Ponti R; Bernengo MG
Dermatology; 2008; 216(3):213-21. PubMed ID: 18182812
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-7 is a growth factor for Sézary lymphoma cells.
Dalloul A; Laroche L; Bagot M; Mossalayi MD; Fourcade C; Thacker DJ; Hogge DE; Merle-Béral H; Debré P; Schmitt C
J Clin Invest; 1992 Sep; 90(3):1054-60. PubMed ID: 1381718
[TBL] [Abstract][Full Text] [Related]
37. T-cell receptor beta-chain usage in directly activated alloreactive CD4+ T cells: unrestricted Vbeta gene usage with CDR3 size limitations.
Zhai Y; Kupiec-Weglinski JW
Transplantation; 2003 Feb; 75(4):514-21. PubMed ID: 12605120
[TBL] [Abstract][Full Text] [Related]
38. Quantitative analysis of T-cell receptor beta variable-gene usage in cutaneous late-phase reactions: implications for T-lymphocyte recruitment in cutaneous inflammation.
Lessin SR; Benoit BM; Li G; Moskovitz A; Zweiman B
Clin Diagn Lab Immunol; 1999 Jan; 6(1):85-8. PubMed ID: 9874669
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of c-myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphoma.
Poenitz N; Simon-Ackermann J; Gratchev A; Qadoumi M; Klemke CD; Stadler R; Kremer A; Radenhausen M; Henke U; Assaf C; Utikal J; Goerdt S; Dippel E
Dermatology; 2005; 211(2):84-92. PubMed ID: 16088151
[TBL] [Abstract][Full Text] [Related]
40. More about the T-cell receptor V beta repertoire usage in mycosis fungoides/Sézary syndrome.
Bachelez H; Gorochov G
Br J Dermatol; 1995 Jun; 132(6):1017-8. PubMed ID: 7662555
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
